PerkinElmer

Maternal & Fetal Health Reagents

PerkinElmer’s prenatal screening assays are clinically validated and ideal for all modern prenatal screening strategies. They were developed to enable the detection of common clinically relevant pregnancy associated conditions such as Down syndrome and preeclampsia, and to provide effective prenatal risk assessment for millions of pregnant women globally every year.

Products may not be licensed in accordance with the laws in all countries, such as the United States and Canada. Please check with your local representative for availability.

Explore Our Maternal & Fetal Health Reagents

Pre-Eclampsia Screening and Prenatal Immunoassays

PerkinElmer offers a comprehensive range of prenatal and pre-eclampsia assays with high analytical sensitivity of the DELFIA® chemistry. The samples can be proc ...

Learn More

Noninvasive Prenatal Testing

Noninvasive prenatal testing (NIPT) consists of analyzing cell-free DNA (cfDNA) circulating in the maternal blood in order to detect Down's syndrome and other f ...

Learn More

Featured Content

Maternal Fetal Health Solutions Brochure

Using the right markers and PerkinElmer’s prenatal assays, combined with one of three scalable technology platforms and the industry-leading informatics of our ...

Learn More

PlGF 1-2-3™ Brochure

PerkinElmer’s PlGF 1-2-3 assay is the most sensitive first trimester screening kit for pre-eclampsia to date.[2] When used in combination with other clinical fa ...

Learn More

Vanadis NIPT system Brochure

With our highly precise, high-throughput Vanadis® NIPT solution, we’re taking much of the complexity out of cell-free DNA (cfDNA) testing, making it accessible ...

Learn More